This is also the case in patients with thyroid cancer, as suggested by Xiao et al. [47], who performed a meta-analysis of 12 independent studies and showed that anti-TG are an independent risk factor, with almost a twofold increase in risk for thyroid cancer. This evidence concerns the gene TG and thyroid gland carcinoma.